You are here: Industry Insights > NPPA

News List

NPPA rejects IPA request for upward price revision of five per cent on all drugs expresspharma
August 20, 2020
According to DEA analysis concluded that some spike in import prices of certain APIs have been witnessed in the post-COVID-19 period, but it does not validate the claim of IPA for a price increase.
NPPA sets up Price Monitoring and Resource Unit in Karnataka expresspharma
August 17, 2020
Karnataka becomes the 13th state to have a PMRU unit which is now registered as 'Karnataka State Price Monitoring Resources Unit Society'.
NPPA issues final guidelines to discontinue making medicines under price control expresspharma
August 17, 2020
The NPPA website will be uploading the list of applications filed by pharma companies and approved by the competent authority for discontinuation.
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData expresspharma
August 04, 2020
Both drugs have seen a sharp decline in price since the availability of the first generic in India.
Pharma experts feel more drugs need price increase expresspharma
July 24, 2020
Recently, NPPA allowed 50 per cent price increase for heparin injection, which is also an essential medicine for the treatment of COVID-19 patients.
NPPA fixes retail prices for 14 formulations expresspharma
July 03, 2020
The fixed formulations are used to treat diabetes, hypertension, cholesterol, women’s health and mental health disorders.
Industry recommends changes in draft guidelines for discontinuation of scheduled formulations expresspharma
June 28, 2020
In the last six months, the National Pharmaceutical Pricing Authority (NPPA) has received several applications from the pharma companies to discontinue their brands from the market.
NPPA issues draft guidelines to tackle cases of discontinuation of scheduled formulations expresspharma
June 04, 2020
The National Pharmaceutical Pricing Authority (NPPA) has issued draft guidelines for dealing with cases of discontinuation of scheduled formulations under para 21 (2) of DPCO 2013.
NPPA fixes retail prices for 40 formulations expresspharma
June 04, 2020
The authority has fixed prices for 40 different formulations produced by 12 manufacturers which applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013.
NPPA releases a list of reduced prices of N-95 masks from manufacturers expresspharma
June 02, 2020
It claims that makers of these masks have voluntarily slashed prices, reportedly up to 47 per cent, after an advisory was issued.

Previous page 1 2 3 4 5 Next page